- Zhejiang Juhua’s net income for the fiscal year is 943.5 million yuan.
- The company reported a revenue of 20.66 billion yuan.
- There has been a decrease in revenue by 3.9% compared to the previous year.
- The company’s stock has received 17 buy recommendations, with no holds or sells.
- All comparisons are based on the company’s original disclosures.
A look at Zhejiang Juhua Co A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have evaluated Zhejiang Juhua Co A utilizing their proprietary Smart Scores system to determine the long-term outlook for the company. With a strong score of 5 for Growth and Momentum, Zhejiang Juhua Co A is projected to excel in expanding its business and maintaining market momentum. Additionally, the company received favorable scores of 3 for both Dividend and Resilience, suggesting a steady dividend payout and ability to weather market volatility. However, Zhejiang Juhua Co A scored lower in the Value category with a score of 2, indicating potential concerns regarding the company’s valuation.
Zhejiang Juhua Co. Ltd., a chemical manufacturer, offers a range of chemical products including alkali, fluoride, ammonia, acid, and biochemical products, among others. Based on the Smart Scores analysis, the company’s strong performance in Growth and Momentum bodes well for its future prospects, while its scores in Dividend and Resilience indicate stability in dividends and market durability. Investors considering Zhejiang Juhua Co A should take note of its overall positive outlook while keeping an eye on valuation metrics.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
